Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02494726 · ClinicalTrials.gov registry record
Prospective Analysis of the Use of TEG in Stroke Patients
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 178
- Enrollment target
NCT02494726: Completed study, sponsored by The University of Texas Health Science Center, Houston.
NCT02494726 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 178 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02494726 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 178 participants
- Enrollment target
Study Summary
The overall purpose of this study is to evaluate how effective Thromboelastography (TEG) is on identifying ischemic and hemorrhagic stroke patients at increased risk for bleeding after receiving tissue plasminogen activator (tPA), as well as on differentiating between patients in whom optimal thrombolysis has been achieved, and those whom it has not.
Primary Outcome
Compare baseline (within 6 hours of last seen normal) TEG in patients with spontaneous ICH to TEG in age-matched controls.
Interventions
- OTHER Thromboelastography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2009-11 |
| Est. Completion | 2014-12 |
What the finished NCT02494726 record still lists
NCT02494726 is an observational study that tracks outcomes without assigning an intervention. The registered 178 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Thromboelastography is the first listed.
NCT02494726 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02494726 about?
NCT02494726 is a clinical study titled "Prospective Analysis of the Use of TEG in Stroke Patients". The overall purpose of this study is to evaluate how effective Thromboelastography (TEG) is on identifying ischemic and hemorrhagic stroke patients at increased risk for bleeding after receiving tissue plasminogen activator (tPA), as well as on differentiating between patients in whom optimal thromb...
What is the current status of trial NCT02494726?
This trial is currently completed. The enrollment target is 178 participants. The study started on 2009-11. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02494726?
The interventions under investigation include: Thromboelastography (OTHER).
Who is sponsoring clinical trial NCT02494726?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03642002 · 178 participants · NA
The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
- NCT04227847 · 178 participants · Phase 1
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
- NCT04855214 · 178 participants
Evaluating the Experience of Upper Limb Prosthesis Use
- NCT05391126 · 178 participants · NA
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia